Bill > H0109

Introduced Session

An act relating to prescription insulin drugs; creating ss. 627.64085 and 627.65746, F.S.; defining the term "prescription insulin drug"; requiring individual and group health insurance policies, respectively, to cap an insured's monthly cost-sharing obligation for covered prescription insulin drugs at a specified amount; providing that coverage for prescription insulin drugs may not be subject to a deductible; providing construction; authorizing the Financial Services Commission to adopt rules; amending s. 627.6699, F.S.; requiring health benefit plans covering small employers to comply with such requirement; amending s. 641.31, F.S.; defining the term "prescription insulin drug"; requiring health maintenance contracts to cap a subscriber's monthly cost-sharing obligation for covered prescription insulin drugs at a specified amount; providing that coverage for prescription insulin drugs may not be subject to a deductible; providing construction; authorizing the commission to adopt rules; providing an effective date.

AI Summary

Committee Categories

Melony Bell (R)*,  Kristen Arrington (D),  Robin Bartleman (D),  Kamia Brown (D),  Anna Eskamani (D),  Joy Goff-Marcil (D),  Michael Grieco (D),  Dotie Joseph (D),  Daisy Morales (D),  Michele Rayner (D),  Felicia Robinson (D),  Kelly Skidmore (D),  Emily Slosberg-King (D),  Carlos Smith (D),  Allison Tant (D),  Jackeline Toledo (R),  Susan L. Valdés (R), 

Died in Finance & Facilities Subcommittee (on 04/30/2021)

Official Document